{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:07:19Z","timestamp":1779167239664,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.kint.2026.02.010","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T09:07:01Z","timestamp":1776676021000},"page":"827-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncoupling glucosuria from infection: SGLT2 inhibition modulates kidney immune response during pyelonephritis"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4056-3030","authenticated-orcid":false,"given":"Laura","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5509-7135","authenticated-orcid":false,"given":"John David","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.02.010_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41574-019-0275-6","article-title":"SGLT2 inhibitors and urinary tract infections","volume":"15","author":"Wilding","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.kint.2026.02.010_bib2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.kint.2026.01.003","article-title":"Sodium glucose transporter 2 inhibition maintains kidney antibacterial response by decreasing complement C1q","volume":"109","author":"Sendtner","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.010_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/cmi.2008.2","article-title":"The classical and regulatory functions of C1q in immunity and autoimmunity","volume":"5","author":"Lu","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.kint.2026.02.010_bib4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41581-023-00737-6","article-title":"Uropathogen and host responses in pyelonephritis","volume":"19","author":"Schwartz","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.02.010_bib5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.imbio.2014.07.004","article-title":"Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro","volume":"219","author":"Pang","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.kint.2026.02.010_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2369-14-63","article-title":"Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis","volume":"14","author":"Tan","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2026.02.010_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12933-021-01430-3","article-title":"SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs","volume":"20","author":"Giugliano","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.kint.2026.02.010_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71231-7","article-title":"Discontinuation rates, clinical effects and provocation factors of SGLT-2 inhibitor in the real world","volume":"14","author":"Bak","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2026.02.010_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/dom.15981","article-title":"Analysing the influence of dapagliflozin on urinary tract infection vulnerability and kidney injury in mice infected with uropathogenic Escherichia coli","volume":"27","author":"Salamon","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.kint.2026.02.010_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/dom.14064","article-title":"Hyperglucosuria induced by dapagliflozin augments bacterial colonization in the murine urinary tract","volume":"22","author":"Saenkham","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.kint.2026.02.010_bib11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/dom.12259","article-title":"Effect of SGLT2 inhibitors in a murine model of urinary tract infection with Candida albicans","volume":"16","author":"Suzuki","year":"2014","journal-title":"Diabetes Obes Metab"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826001523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826001523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:15:06Z","timestamp":1779164106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0085253826001523"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.02.010","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncoupling glucosuria from infection: SGLT2 inhibition modulates kidney immune response during pyelonephritis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.01.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}